^
    Back
    Association details:
    Biomarker:HR positive
    Cancer:Hormone Receptor Positive Breast Cancer
    Drug Class:Aromatase inhibitor
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    Source:
    ASCO.org
    Title:

    Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer

    Published date:
    05/23/2016
    Excerpt:
    First-Line Therapy: Postmenopausal women with HR-positive MBC should be offered aromatase inhibitors (AIs) as part of first-line endocrine therapy.
    DOI:
    10.1200/JCO.2016.67.1487